血液処理用ディスポーザブル市場：製品別、用途別-2025-2030年の世界予測

血液処理用ディスポーザブル市場は、2023年に114億6,000万米ドルと評価され、2024年には126億9,000万米ドルに達すると予測され、CAGR 10.75％で成長し、2030年には234億3,000万米ドルに達すると予測されています。

血液処理用ディスポーザブルには、血液とその成分を安全かつ効率的に収集、処理、保管、輸血するために設計された一連の製品が含まれます。これらには、採血バッグ、フィルター、ランセット、チューブセットなどが含まれ、病院、血液銀行、検査室における診断・治療介入に不可欠です。これらの製品の必要性は、外科手術の増加、外傷症例、貧血などの血液疾患によって拍車がかかった輸血需要の増加から生じています。用途別では、様々な医療用途の血液成分の分離に極めて重要であり、無菌性、安全性、血液製剤の効率的な取り扱いを保証します。最終用途の範囲はヘルスケア環境、調査施設、単独献血キャンプにまで及び、医療インフラにおける不可欠性を強調しています。

主な市場成長要因としては、ヘルスケアインフラの進歩、慢性疾患の流行、血液安全技術の革新などが挙げられます。最新のビジネスチャンスは、進化するヘルスケア需要と新興市場への投資によってもたらされ、改良された費用対効果の高いディスポーザブルの必要性が強調されています。企業は、自動血液処理システムの研究開発を強化し、より良い管理とトレーサビリティのためにデジタル追跡ソリューションを統合することで、これらを活用することができます。しかし、厳しい規制承認や使い捨て品の環境への影響をめぐる問題には限界があり、環境に優しい素材や廃棄物管理ソリューションの革新が必要です。

さらに、高コスト、低所得地域でのアクセス制限、（COVID-19のような）パンデミック時のサプライチェーンの混乱といった課題も市場力学に影響を与えています。革新的な成長分野としては、リアルタイムのモニタリング機能を備えた多機能ディスポーザブルの開発や、AIを活用して血液需要を正確に予測することなどが考えられます。市場の競争は激しいが有望であり、患者の安全性向上と血液資源の効率的管理に重点が置かれています。俊敏な戦略とコラボレーションによってこれらの洞察を活用する態勢を整えた企業は、大きな市場シェアを獲得し、ヘルスケア部門全体に世界の影響力を拡大することができます。

市場力学：急速に進化する血液処理用ディスポーザブル市場の主要市場インサイトを公開

血液処理用ディスポーザブル市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 感染症の流行と採血ニーズの高まり
  • 自発的な献血キャンペーンの増加
  • 輸血の安全性を促進するヘルスケア政策のアップグレードの増加
• 市場抑制要因
  • 輸血による汚染や病気のトランスミッションのリスク
• 市場機会
  • ハイテク使い捨て製品を製造するための研究開発への投資
  • 環境に優しい製造プロセスの採用による環境に優しいディスポーザブルの開発
• 市場の課題
  • 使い捨て血液処理製品のリコール問題

ポーターのファイブフォース：血液処理用ディスポーザブル市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：血液処理用ディスポーザブル市場における外部からの影響の把握

外部マクロ環境要因は、血液処理用ディスポーザブル市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析血液処理用ディスポーザブル市場における競合情勢の把握

血液処理用ディスポーザブル市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス血液処理用ディスポーザブル市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、血液処理用ディスポーザブル市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨血液処理用ディスポーザブル市場における成功への道筋を描く

血液処理用ディスポーザブル市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 感染症の蔓延と血液採取の必要性の高まり
    • 自発的な献血キャンペーンの増加
    • 輸血の安全性を促進するヘルスケア政策の強化が進む
  • 抑制要因
    • 輸血による汚染や病気のトランスミッションのリスク
  • 機会
    • ハイテク使い捨て製品を生産するための研究開発への投資
    • より環境に優しい製造プロセスを採用した環境に優しい使い捨て製品の開発
  • 課題
    • 使い捨て血液処理製品の製品リコール問題
• 市場セグメンテーション分析
  • 製品：診断と患者ケアにおける重要な役割により、採血管の使用が増加しています。
  • 最終用途：病院における血液処理用ディスポーザブルの需要増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 血液処理用ディスポーザブル市場：製品別

• 血液投与セット
• 血液バッグ
• 採血針
• 採血管
• 血液フィルター
• 血液ランセット
• 凝固試薬
• 血液学試薬
• 顕微鏡スライド
• 沈殿管
• スライド染色装置
• 試験管ラック
• バイアル

第7章 血液処理用ディスポーザブル市場：最終用途別

• 学術機関
• 血液銀行
• クリニック
• 診断センター
• 病院

第8章 南北アメリカの血液処理用ディスポーザブル市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の血液処理用ディスポーザブル市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの血液処理用ディスポーザブル市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • Cml Biotechが統合型採血管製造機を導入
  • DBT研究所、血液の保存期間を延ばす新しいバッグを開発
• 戦略分析と提言

企業一覧

• 3M Company
• Abbott Laboratories
• Advin Health Care
• Beckman Coulter, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• BIO-X
• Cardinal Health, Inc.
• Fresenius Kabi AG
• GE HealthCare Technologies Inc.
• Grifols, S.A.
• Haemonetics Corporation
• Kawasumi Laboratories, Inc.
• Labtech Disposables
• Maco Pharma SAS
• Medtronic plc
• Merck KGaA
• Narang Medical Limited
• Qiagen N.V.
• SARSTEDT AG & Co.
• Siemens Healthineers AG
• TERUMO BCT, INC.
• Terumo Corporation
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. BLOOD PROCESSING DISPOSABLES MARKET RESEARCH PROCESS
• FIGURE 2. BLOOD PROCESSING DISPOSABLES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. BLOOD PROCESSING DISPOSABLES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. BLOOD PROCESSING DISPOSABLES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BLOOD PROCESSING DISPOSABLES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BLOOD PROCESSING DISPOSABLES MARKET DYNAMICS
• TABLE 7. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD ADMINISTRATION SETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COLLECTION TUBES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD FILTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD LANCETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COAGULATION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY HEMATOLOGY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MICROSCOPIC SLIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEDIMENTATION TUBES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SLIDE STAINERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TEST TUBE RACKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY VIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 34. CANADA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. CANADA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 46. CHINA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. CHINA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 48. INDIA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. INDIA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 52. JAPAN BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 54. MALAYSIA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. MALAYSIA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 56. PHILIPPINES BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. PHILIPPINES BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 58. SINGAPORE BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. SINGAPORE BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 60. SOUTH KOREA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. SOUTH KOREA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 62. TAIWAN BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. TAIWAN BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 64. THAILAND BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. THAILAND BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 66. VIETNAM BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. VIETNAM BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 68. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 70. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 71. DENMARK BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. DENMARK BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 73. EGYPT BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. EGYPT BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 75. FINLAND BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. FINLAND BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 77. FRANCE BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. FRANCE BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 79. GERMANY BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. GERMANY BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 81. ISRAEL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. ISRAEL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 83. ITALY BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. ITALY BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 85. NETHERLANDS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. NETHERLANDS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 87. NIGERIA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. NIGERIA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 89. NORWAY BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. NORWAY BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 91. POLAND BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. POLAND BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 93. QATAR BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. QATAR BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 95. RUSSIA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. RUSSIA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 97. SAUDI ARABIA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. SAUDI ARABIA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 99. SOUTH AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. SOUTH AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 101. SPAIN BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. SPAIN BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 103. SWEDEN BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. SWEDEN BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 105. SWITZERLAND BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. SWITZERLAND BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 107. TURKEY BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. TURKEY BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 109. UNITED ARAB EMIRATES BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. UNITED ARAB EMIRATES BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 111. UNITED KINGDOM BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. UNITED KINGDOM BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 113. BLOOD PROCESSING DISPOSABLES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 114. BLOOD PROCESSING DISPOSABLES MARKET, FPNV POSITIONING MATRIX, 2023

The Blood Processing Disposables Market was valued at USD 11.46 billion in 2023, expected to reach USD 12.69 billion in 2024, and is projected to grow at a CAGR of 10.75%, to USD 23.43 billion by 2030.

Blood processing disposables encompass a range of products designed for collecting, processing, storing, and transfusing blood and its components safely and efficiently. These include collection bags, filters, lancets, and tubing sets, which are integral in diagnostic and therapeutic interventions in hospitals, blood banks, and laboratories. The necessity of these products arises from the increasing demand for blood transfusions, spurred by rising surgical procedures, trauma cases, and blood disorders like anemia. Application-wise, they are crucial in separating blood components for various medical uses, ensuring sterility, safety, and efficiency in handling blood products. The end-use scope extends to healthcare settings, research facilities, and standalone blood donation camps, emphasizing their indispensability in health infrastructure.

Key market growth factors include advancing healthcare infrastructure, the prevalence of chronic diseases, and innovations in blood safety technologies. Latest opportunities are driven by evolving healthcare demands and investments in emerging markets, emphasizing the need for improved and cost-effective disposables. Companies can capitalize on these by enhancing R&D towards automated blood processing systems and integrating digital tracking solutions for better management and traceability. However, limitations exist in stringent regulatory approvals and issues surrounding the environmental impact of disposables, necessitating innovation in eco-friendly materials and waste management solutions.

Moreover, challenges such as high costs, limited access in low-income regions, and supply chain disruptions during pandemics (like COVID-19) affect market dynamics. Innovative areas for growth could include developing multi-functional disposables with real-time monitoring capabilities and leveraging AI to predict blood demand accurately. The nature of the market is competitive yet promising, underscored by a growing focus on improving patient safety and managing blood resources effectively. Enterprises poised to leverage these insights with agile strategies and collaborations can capture significant market share, proliferating their impact across healthcare sectors globally.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Processing Disposables Market

The Blood Processing Disposables Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of infectious diseases and the rising need for blood collection
  • Increasing voluntary blood donation campaigns
  • Growing upgradations in healthcare policies promoting blood transfusion safety
• Market Restraints
  • Risk of contamination and transmission of diseases through transfusion
• Market Opportunities
  • Investments in R&D to produce high-tech disposables
  • Development of eco-friendly disposables with adoption of greener manufacturing processes
• Market Challenges
  • Issues of product recalls for disposable blood processing products

Porter's Five Forces: A Strategic Tool for Navigating the Blood Processing Disposables Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Processing Disposables Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Processing Disposables Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Processing Disposables Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Processing Disposables Market

A detailed market share analysis in the Blood Processing Disposables Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Processing Disposables Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Processing Disposables Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Processing Disposables Market

A strategic analysis of the Blood Processing Disposables Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Processing Disposables Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Advin Health Care, Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BIO-X, Cardinal Health, Inc., Fresenius Kabi AG, GE HealthCare Technologies Inc., Grifols, S.A., Haemonetics Corporation, Kawasumi Laboratories, Inc., Labtech Disposables, Maco Pharma SAS, Medtronic plc, Merck KGaA, Narang Medical Limited, Qiagen N.V., SARSTEDT AG & Co., Siemens Healthineers AG, TERUMO BCT, INC., Terumo Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Blood Processing Disposables Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Blood Administration Sets, Blood Bags, Blood Collection Needles, Blood Collection Tubes, Blood Filters, Blood Lancets, Coagulation Reagents, Hematology Reagents, Microscopic Slides, Sedimentation Tubes, Slide Stainers, Test Tube Racks, and Vials.
• Based on End-Use, market is studied across Academic Institutes, Blood Banks, Clinics, Diagnostic Centers, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of infectious diseases and the rising need for blood collection
    • 5.1.1.2. Increasing voluntary blood donation campaigns
    • 5.1.1.3. Growing upgradations in healthcare policies promoting blood transfusion safety
  • 5.1.2. Restraints
    • 5.1.2.1. Risk of contamination and transmission of diseases through transfusion
  • 5.1.3. Opportunities
    • 5.1.3.1. Investments in R&D to produce high-tech disposables
    • 5.1.3.2. Development of eco-friendly disposables with adoption of greener manufacturing processes
  • 5.1.4. Challenges
    • 5.1.4.1. Issues of product recalls for disposable blood processing products
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Rising use of blood collection tubes owing to their critical role in diagnostics and patient care
  • 5.2.2. End-Use: Growing need for blood processing disposables in hospitals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Blood Processing Disposables Market, by Product

• 6.1. Introduction
• 6.2. Blood Administration Sets
• 6.3. Blood Bags
• 6.4. Blood Collection Needles
• 6.5. Blood Collection Tubes
• 6.6. Blood Filters
• 6.7. Blood Lancets
• 6.8. Coagulation Reagents
• 6.9. Hematology Reagents
• 6.10. Microscopic Slides
• 6.11. Sedimentation Tubes
• 6.12. Slide Stainers
• 6.13. Test Tube Racks
• 6.14. Vials

7. Blood Processing Disposables Market, by End-Use

• 7.1. Introduction
• 7.2. Academic Institutes
• 7.3. Blood Banks
• 7.4. Clinics
• 7.5. Diagnostic Centers
• 7.6. Hospitals

8. Americas Blood Processing Disposables Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Blood Processing Disposables Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Blood Processing Disposables Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. Cml Biotech Installed an Integrated Blood Collection Tube Manufacturing Machine
  • 11.3.2. DBT Institute Develops Novel Bags To Increase Shelf Life Of Blood
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. Abbott Laboratories
• 3. Advin Health Care
• 4. Beckman Coulter, Inc.
• 5. Becton, Dickinson and Company
• 6. Bio-Rad Laboratories, Inc.
• 7. BIO-X
• 8. Cardinal Health, Inc.
• 9. Fresenius Kabi AG
• 10. GE HealthCare Technologies Inc.
• 11. Grifols, S.A.
• 12. Haemonetics Corporation
• 13. Kawasumi Laboratories, Inc.
• 14. Labtech Disposables
• 15. Maco Pharma SAS
• 16. Medtronic plc
• 17. Merck KGaA
• 18. Narang Medical Limited
• 19. Qiagen N.V.
• 20. SARSTEDT AG & Co.
• 21. Siemens Healthineers AG
• 22. TERUMO BCT, INC.
• 23. Terumo Corporation
• 24. Thermo Fisher Scientific Inc.